EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors

Allison J Nipper iD, Emilie A K Warren iD, Kershena S Liao, Hsuan-Chen Liu, Chieko Michikawa, Caroline E Porter iD, Gabrielle A Wells iD, Mariana Villanueva iD, Fabio Henrique Brasil da Costa, Ratna Veeramachaneni, Hugo Villanueva, Masataka Suzuki iD und 1 weitere

ImmunoHorizons · 2024

DOI: 10.4049/immunohorizons.2400059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Allison J Nipper und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Chorioallantoic Membrane, Receptors, Chimeric Antigen, Erb-b2 Receptor Tyrosine Kinases, Immunotherapy, Adoptive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fertilized chicken egg chorioallantoic membrane (CAM), a highly vascularized membrane nourishing the developing embryo, also supports rapid growth of three-dimensional vascularized tumors from engrafted cells and tumor explants. Because murine xenograft models suffer limitations of time, cost, and scalability, we propose CAM tumors as a rapid, efficient screening tool for assessing anti-tumor efficacy of chimeric Ag receptor (CAR) T cells against solid tumors. We tested the efficacy of human epidermal growth factor receptor 2 (HER2)–specific CAR T cells against luminescent, HER2-expressing (FaDu, SCC-47) or HER2-negative (MDA-MB-468) CAM-engrafted tumors. Three days after tumor engraftment, HER2-specific CAR T cells were applied to tumors grown on the CAM. Four days post–CAR T cell treatment, HER2-expressing FaDu and SCC-47 tumors treated with CAR T showed reduced viable cancer cells as assessed by luciferase activity. This reduction in viable tumor cells was confirmed by histology, with lower Ki-67 staining observed in CAR T cell–treated tumors relative to T cell–treated controls. Persistence of CAR T in CAM and tumor tissue 4 days post-treatment was confirmed by CD3 staining. Altogether, our findings support further development of the chick CAM as an in vivo system for rapid, scalable screening of CAR T cell efficacy against human solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chorioallantoic MembraneReceptors, Chimeric AntigenErb-b2 Receptor Tyrosine KinasesImmunotherapy, AdoptiveAnimalsChick EmbryoHumansCell Line, TumorXenograft Model Antitumor AssaysT-LymphocytesMiceNeoplasmsFemale

Substanzen

Receptors, Chimeric AntigenErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX.
  • Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX.
  • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX.
  • Advanced Technology Cores, Baylor College of Medicine, Houston, TX.
  • Texas Children's Hospital, Houston, TX.

ORCID-Profile: Allison J Nipper, Emilie A K Warren, Caroline E Porter, Gabrielle A Wells, Mariana Villanueva, Masataka Suzuki, Andrew G Sikora

Förderung

  • NCI NIH HHS

Zitieren

APA

Nipper, A. J., Warren, E. A. K., Liao, K. S., Liu, H. C., Michikawa, C., Porter, C. E., Wells, G. A., Villanueva, M., Brasil da Costa, F. H., Veeramachaneni, R., Villanueva, H., Suzuki, M., & Sikora, A. G. (2024). Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400059

Vancouver

Nipper AJ, Warren EAK, Liao KS, Liu HC, Michikawa C, Porter CE, et al. Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400059

BibTeX
@article{Nipper2024,
  author = {Nipper, Allison J and Warren, Emilie A K and Liao, Kershena S and Liu, Hsuan-Chen and Michikawa, Chieko and Porter, Caroline E and Wells, Gabrielle A and Villanueva, Mariana and Brasil da Costa, Fabio Henrique and Veeramachaneni, Ratna and Villanueva, Hugo and Suzuki, Masataka and Sikora, Andrew G},
  title = {Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors},
  journal = {ImmunoHorizons},
  year = {2024},
  doi = {10.4049/immunohorizons.2400059}
}
Kostenlos starten →